UCBJY

UCB SA UNSP/ADR by UCB S.A. (UCBJY)

About UCB SA UNSP/ADR by UCB S.A. (UCBJY)

UCB SA engages in the research and development of biopharmaceuticals products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium.

Details

Daily high

$86.59

Daily low

$84.80

Price at open

$84.81

52 Week High

$106.60

52 Week Low

$63.58

Market cap

32.0B

Dividend yield

0.87%

Volume

29,227

Avg. volume

57,310

P/E ratio

27.75

UCB SA UNSP/ADR by UCB S.A. News